Humoral immune responses in brushtail possums (Trichosurus vulpecula) induced by bacterial ghosts expressing possum zona pellucida 3 protein

Vaccine

Volumn 28, Issue 26, 2010, Pages 4268-4274

  Cui, Xianlan ^a   Duckworth, Janine A ^a   Lubitz, Petra ^b,c   Molinia, Frank C ^a   Haller, Christoph ^b,c   Lubitz, Werner ^b,c   Cowan, Phil E ^d  

^a LANDCARE RESEARCH   (New Zealand)

^b UNIVERSITY OF VIENNA   (Austria)

^c BIRD C GmbH and CoKEG   (Austria)

^d LANDCARE RESEARCH   (New Zealand)

Author keywords

Bacterial ghosts (BGs); Brushtail possum; Immunogenicity; Mucosal immunisation; Zona pellucida

Indexed keywords

MEMBRANE FUSION PROTEIN; UNCLASSIFIED DRUG; ZONA PELLUCIDA 3 PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL MEMBRANE; BACTERIOPHAGE; BIOLOGICAL PEST CONTROL; BIRTH CONTROL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; GENITAL SYSTEM; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOCONTRACEPTION; IMMUNOGENICITY; MOLECULAR CLONING; MUCOSAL IMMUNITY; NONHUMAN; OVARY FOLLICLE FLUID; OVIDUCT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; STOMACH PH; TRICHOSURUS; WILD ANIMAL; ZONA PELLUCIDA;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES; ANTIBODY FORMATION; EGG PROTEINS; ESCHERICHIA COLI; FEMALE; MEMBRANE GLYCOPROTEINS; PLASMIDS; RECEPTORS, CELL SURFACE; RECOMBINANT FUSION PROTEINS; TRICHOSURUS; VACCINES, CONTRACEPTIVE;

EID: 77952744384     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.032     Document Type: Article

References (46)

1. Cowan P. Biological control of possums: prospects for the future. In: Montague T.L. (Ed). The brushtail possum: biology, impact and management of an introduced marsupial (2000), Manaaki Whenua Press, Lincoln, New Zealand 262-270
2. Mate K.E., and Hinds L.A. Contraceptive vaccine development for wildlife management. In: Holt W.V., Pickard A.R., Rodger J.C., and Wildt D.E. (Eds). Reproductive science and integrated conservation. Conservation biology 8 (2003), Cambridge University Press, Cambridge 291-304
3. Duckworth J.A., Harris M., Mate K., McCartney C., Buist J., Scobie S., et al. Development of brushtail possum immunocontraception: targeting sperm and egg antigens. In: Sutherland G. (Ed). Advances in the biological control of possums. R Soc NZ Misc Ser vol. 56 (1999) 72-76
4. Cui X., and Duckworth J.A. Mapping of B cell epitopes on the zona pellucida 2 protein of a marsupial, the brushtail possum (Trichosurus vulpecula). Mol Reprod Dev 70 (2005) 485-493
5. Duckworth J.A., Byrom A.E., Fisher P., and Horn C. Pest control: does the answer lie in new biotechnologies?. In: Allen R.B., and Lee W.G. (Eds). Biological invasions in New Zealand. Ecol. Studies 186 (2006), Springer-Verlag, Berlin 421-434
6. Witte W., Braulke C., Halle E., Spencker F.B., and Handrick W. Typing of multiple isolates of coagulase-negative staphylococci from blood cultures and cerebrospinal fluid in neonates and children: an approach to discriminate contaminants. Zentralbl Bakteriol 274 (1990) 382-389
7. Szostak M.P., Hensel A., Eko F.O., Klein R., Auer T., Mader H., et al. Bacterial ghosts: non-living candidate vaccines. J Biotechnol 44 (1996) 161-170
8. Witte A., Wanner G., Sulzner M., and Lubitz W. Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli. Arch Microbiol 157 (1992) 381-388
9. Eko F.O., Witte A., Huter V., Kuen B., Furst-Ladani S., Haslberger A., et al. New strategies for combination vaccines based on the extended recombinant bacterial ghost system. Vaccine 17 (1999) 1643-1649
10. Marchart J., Dropmann G., Lechleitner S., Schlapp T., Wanner G., Szostak M.P., et al. Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidates. Vaccine 21 (2003) 3988-3997
11. Marchart J., Rehagen M., Dropmann G., Szostak M.P., Alldinger S., Lechleitner S., et al. Protective immunity against pasteurellosis in cattle, induced by Pasteurella haemolytica ghosts. Vaccine 21 (2003) 1415-1422
12. Panthel K., Jechlinger W., Matis A., Rohde M., Szostak M., Lubitz W., et al. Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates. Infect Immun 71 (2003) 109-116
13. Lubitz W., Witte A., Eko F.O., Kamal M., Jechlinger W., Brand E., et al. Extended recombinant bacterial ghost system. J Biotechnol 3 (1999) 261-273
14. Kuen B., Sleytr U.B., and Lubitz W. Sequence analysis of the sbsA gene encoding the 130-kDa surface-layer protein of Bacillus stearothermophilus strain PV72. Gene 145 (1994) 115-120
15. Kuen B., Sara M., and Lubitz W. Heterologous expression and self-assembly of the S-layer protein SbsA of Bacillus stearothermophilus in Escherichia coli. Mol Microbiol 19 (1996) 495-503
16. Kuen B., Koch A., Asenbauer E., Sara M., and Lubitz W. Molecular characterization of the Bacillus stearothermophilus PV72 S-layer gene sbsB induced by oxidative stress. J Bacteriol 179 (1997) 1664-1670
17. Truppe M., Horworka S., Schroll G., Lechleitner S., Kuen B., Resch S., et al. Biotechnological applications of recombinant S-layer proteins rSbsA and rSbsB from Bacillus stearothermophilus PV72. FEMS Microbiol Rev 20 (1997) 88-98
18. Howorka S., Sara M., Wang Y., Kuen B., Sleytr U.B., Lubitz W., et al. Surface-accessible residues in the monomeric and assembled forms of a bacterial surface layer protein. J Biol Chem 275 (2000) 37876-37886
19. Walcher P., Mayr U.B., Azimpour-Tabrizi C., Eko F.O., Jechlinger W., Mayrhofer P., et al. Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors. Expert Rev Vaccines 3 (2004) 681-691
20. Jalava K., Hensel A., Szostak M., Resch S., and Lubitz W. Bacterial ghosts as vaccine candidates for veterinary applications. J Control Release 85 1-3 (2002) 17-25
21. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: a laboratory manual (1989), Cold Spring Harbor Laboratory Press
22. Mate K.E., Buist J.M., and Duckworth J.A. Expression in Escherichia coli and immunological characterization of three zona pellucida proteins (ZP1, ZP2, ZP3) from a marsupial, the brushtail possum (Trichosurus vulpecula). Mol Reprod Dev 64 (2003) 136-143
23. Buddle B.M., Aldwell F.E., Jowett G., Thomson R., Jackson R., and Paterson B.M. Influence of stress of capture on haematological values and cellular immune responses in the Australian brushtail possum (Trichosurus vulpecula). N Z Vet J 40 (1992) 155-159
24. Molinia F.C., Gibson R.J., Brown A.M., Glazier A.M., and Rodger J.C. Successful fertilization after superovulation and laparoscopic intrauterine insemination of the brushtail possum, Trichosurus vulpecula, and tammar wallaby, Macropus eugenii. J Reprod Fertil 113 (1998) 9-17
25. Duckworth J., Wilson K., Cui X., Molinia F., and Cowan P. Immunogenicity and contraceptive potential of three infertility relevant possum ZP2 epitopes in the Brushtail Possum (Trichosurus vulpecula). Reproduction 133 (2007) 177-186
26. Bastien N., Trudel M., and Simard C. Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines. Vaccine 17 (1999) 832-836
27. Hoy J.W., Grisham M.P., and Damann K.E. Spread and increase of ratoon stunting disease of sugarcane and comparison of disease detection methods. Plant Dis 83 (1999) 1170-1175
28. Greenbauma E., Furst A., Kiderman A., Stewart B., Levy R., Schlesinger M., et al. Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine. Vaccine 20 (2002) 1232-1239
29. Crawley M.J. Statistical computing: an introduction to data analysis using S-Plus (2002), UK Wiley, Chichester
30. Morgan D., and Hickling G. Techniques used for poisoning possums. In: Montague T.L. (Ed). The brushtail possum: biology, impact and management of an introduced marsupial (2000), Manaaki Whenua Press, Lincoln, New Zealand 143-153
31. Eberspaecher U., Becker A., Bringmann P., van der Merwe L., and Donner P. Immunohistochemical localization of zona pellucida proteins ZPA, ZPB and ZPC in human, cynomolgus monkey and mouse ovaries. Cell Tissue Res 303 (2001) 277-287
32. Goldberg M., and Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov 2 4 (2003) 289-295
33. Khalil A.M., McFarlane R.G., and Duckworth J.A. Humoral immunity to cholera toxin and ovalbumin in the brushtail possum (Trichosurus vulpecula). N Z Vet J 49 2 (2001) 54-59
34. Hobson P., Barnfield C., Barnes A., and Klavinskis L.S. Mucosal immunization with DNA vaccines. Methods 31 (2003) 217-224
35. Holmgren J., Czerkinsky C., Eriksson K., and Mharandi A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 21 Suppl. 2 (2003) S89-S95
36. Byun Y., Ohmura M., Fujihashi K., Yamamoto S., McGhee J.R., Udaka S., et al. Nasal immunization with E. coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies. Vaccine 19 (2001) 2061-2070
37. Singh M., and O'Hagan D.T. Recent advances in veterinary vaccine adjuvants. Int J Parasitol 33 (2003) 469-478
38. Kutteh W.H. Mucosal immunity in the human female reproductive tract. In: Ogra P.L., Mestecky J., Lamm M.E., Strober W., Bienenstock J., and McGhee J.R. (Eds). Mucosal immunology. 2nd ed. (1999), Academic Press, San Diego, CA 1423-1431
39. Winterfield R.W., Dhillon A.S., and Alby L.J. Vaccination of chickens against Newcastle disease with live and inactivated Newcastle disease virus. Poult Sci 59 (1980) 240-246
40. Andrade L.F., Villegas P., and Fletcher O.J. Vaccination of day-old broilers against infectious bronchitis: effect of vaccine strain and route of administration. Avian Dis 27 (1983) 178-187
41. Jayawardane G.W., and Spradbrow P.B. Mucosal immunity in chickens vaccinated with the V4 strain of Newcastle disease virus. Vet Microbiol 46 (1995) 69-77
42. Thekisoe M.M., Mbati P.A., and Bisschop S.P. Different approaches to the vaccination of free ranging village chickens against Newcastle disease in Qwa-Qwa, South Africa. Vet Microbiol 101 (2004) 23-30
43. Czerkinsky C., Anjuere F., McGhee J.R., George-Chandy A., Holmgren J., Kieny M.P., et al. Mucosal immunity and tolerance: relevance to vaccine development. Immunol Rev 170 (1999) 197-222
44. Knop E., and Knop N. Eye-associated lymphoid tissue (EALT) is continuously spread throughout the ocular surface from the lacrimal gland to the lacrimal drainage system. Ophthalmologe 100 (2003) 929-942
45. Sullivan D.A. Ocular mucosal immunity. In: Ogra P.L., Mestecky J., Lamm M.E., Strober W., Bienenstock J., and McGhee J.R. (Eds). Mucosal immunology (1999), Academic Press, San Diego, CA 1241-1281
46. Walcher P., Cui X., Arrow J., Scobie S., Molinia F.C., Cowan P., et al. Bacterial ghosts as a delivery systems for zona pellucida-2 fertility control vaccines for brushtail possums (Trichosurus vulpecula). Vaccine 26 (2008) 6832-6838